Keywords: Northern Europe, Outlook, Espicom, Denmark, Sweden, Norway, Lithuania, Finland

Outlook for pharmaceuticals in Northern Europe - seven markets valued at $16.3 billion

Article | 24 December 2010

The seven Northern European markets for pharmaceuticals are diverse, from the stable well-developed markets of Scandinavia to the less well-funded ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in